SGMO
SGMO
NASDAQ · Biotechnology

Sangamo Therapeutics Inc

$0.11
+0.00 (+3.77%)
Day Range $0.10 — $0.11
52W Range $0.01 — $0.60
Open$0.10
Previous Close$0.11
Day High$0.11
Day Low$0.10
52W High$0.60
52W Low$0.01
Volume—
Avg Volume895.4K
Market Cap47.23M
P/E Ratio—
EPS$-0.38
SectorBiotechnology

Analyst Ratings

Strong Buy
7 analysts
6 Buy 1 Hold 0 Sell
Price Target +18,345.5% upside
Current
$0.11
Target
$20.29
$11.90 $20.29 avg $29.33

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 60.62M 85.59M 23.70M
Net Income -188,357,551 -239,336,151 -3,056,252
Profit Margin -310.8% -295.3% -12.9%
EBITDA -179,727,538 -241,057,688 -4,785,189
Free Cash Flow — — -2,136,953
Rev Growth -29.2% -29.2% +16.7%
Debt/Equity — — 0.64

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $294.55 -0.16% 50.3 520.47B
AMGN Amgen Inc $456.60 -1.24% 26.9 252.64B
GILD Gilead Sciences Inc $169.42 +1.10% — 208.95B
VRTX Vertex Pharmaceuticals Inc $531.97 -1.08% 33.9 134.82B
REGN Regeneron Pharmaceuticals $951.08 -0.14% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $159.73 -3.22% 7.7 20.98B

Quick Stats

Market Cap47.23M
P/E Ratio—
EPS$-0.38
Volume—
SectorBiotechnology